Inactive Instrument
Pressure BioSciences, Inc. Stock Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 126K 116K 109K 204K 13.58M 207K 1.4M 539K 6.66M 538K 527K 23.17M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.16M 18.58M 17.39M 32.61M 2.17B 33.19M 223M 86.23M 1.07B 86.15M 84.28M 3.71B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 2004-04-15 | |
| Chief Tech/Sci/R&D Officer | 61 | 2006-04-02 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 2006-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 1991-12-31 | |
Michael Urdea
BRD | Director/Board Member | 73 | 2013-02-07 |
Jeffrey Peterson
CHM | Chairman | 70 | 2012-08-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 51.56K | ||
| +1.15% | -0.92% | +17.96% | -11.16% | 172B | ||
| +0.06% | -3.21% | -20.85% | +23.07% | 143B | ||
| +0.44% | -1.18% | -8.87% | -24.29% | 126B | ||
| +2.86% | -2.48% | -54.99% | -16.54% | 65.89B | ||
| +1.25% | +0.78% | +17.77% | -4.80% | 49.45B | ||
| +0.06% | -1.26% | -25.33% | -31.86% | 44.05B | ||
| +0.14% | -3.00% | +9.61% | +6.73% | 35.72B | ||
| -0.29% | -0.16% | +4.25% | +37.24% | 35.18B | ||
| +5.08% | -1.61% | -10.61% | -20.56% | 27.58B | ||
| Average | +1.08% | -2.49% | -7.89% | -4.69% | 77.68B | |
| Weighted average by Cap. | +0.93% | -2.43% | -6.66% | -4.92% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.4M 1.31M 2.46M 164M 2.5M 16.83M 6.5M 80.33M 6.49M 6.35M 279M | 1.98M 1.74M 1.6M 1.5M 2.81M 187M 2.86M 19.25M 7.43M 91.87M 7.42M 7.26M 320M |
| Net income | -16.08M -14.13M -13.02M -12.18M -22.85M -1.52B -23.25M -156M -60.41M -747M -60.35M -59.04M -2.6B | -29.31M -25.76M -23.73M -22.21M -41.66M -2.78B -42.4M -285M -110M -1.36B -110M -108M -4.74B |
| Net Debt | 20.53M 18.04M 16.62M 15.55M 29.17M 1.94B 29.69M 200M 77.12M 953M 77.05M 75.38M 3.32B | 22.8M 20.04M 18.46M 17.28M 32.41M 2.16B 32.99M 222M 85.69M 1.06B 85.61M 83.75M 3.68B |
Employees
-
















